
AdvaMed COVID Testing Supply Registry – Weekly Report
This report outlines a key data-driven summary of the U.S. COVID testing supply.
My Profile
Policy
On behalf of our members, AdvaMed works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.
This report outlines a key data-driven summary of the U.S. COVID testing supply.
These arrangements to advance value-based care are designed to increase shared accountability among shareholders for quality of, access to and/or the total cost of care.
A comprehensive training deck that companies can pull from depending on the setting and need.
A “Crosswalk” comparing the revised AdvaMed Code with the other codes of ethics, to include: PhRMA; MedTech Europe; and Mecomed.
This Guidance Document provides companies with direction on implementing legitimate, bona fide training and education programs.
AdvaMed urged CDC to recognize the critical role evidence-based and FDA-approved/cleared devices can and should play in improving pain management and reducing opioid-related harms.
This report outlines a key data-driven summary of the U.S. COVID testing supply.
These arrangements to advance value-based care are designed to increase shared accountability among shareholders for quality of, access to and/or the total cost of care.
A comprehensive training deck that companies can pull from depending on the setting and need.
A “Crosswalk” comparing the revised AdvaMed Code with the other codes of ethics, to include: PhRMA; MedTech Europe; and Mecomed.
AdvaMed members have access to our full library of industry resources.
The Advanced Medical Technology Association (AdvaMed), the world’s largest trade organization representing medical technology manufacturers, announced its new role in the Biden Administration’s Joint Supply Chain Resilience Working Group.
Scott Whitaker, president and CEO of AdvaMed, the world’s largest trade association representing medical technology companies, released the following statement on progress this week in both houses of Congress.
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association (AdvaMed) released this statement from President and CEO Scott Whitaker.
AdvaMed is collaborating with the U.S. and Ukrainian governments to facilitate donations of urgently needed medical supplies to Ukraine.
The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs support scientific development and product innovation benefiting patients in need and the public at large.
BlueWind Medical, Ltd., AdvaMed member and developer of the innovative RENOVA iStim™ implantable tibial neuromodulation (iTNM) device for treatment of Overactive Bladder, today announced the addition of Charles F. (“Chuck”)…
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association (AdvaMed) released this statement from President and CEO Scott Whitaker.
Scott Whitaker, President and CEO of AdvaMed, led a meeting of medtech CEOs and leaders with Secretary of Commerce Gina Raimondo to discuss semiconductor chip supply chain issues impacting the…
On patient safety, there is no substitution for the extensive training, knowledge, and expertise authorized servicers must have to maintain and repair complex medical technology.
The AdvaMed Code helps guide medical technology companies to develop and structure internal controls and self-regulatory principles in a way that addresses important legal risks.
We are pleased to provide AdvaMed members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.